Severe COVID-19 sufferers demonstrated increased levels of non-classical monocytes, several plasma chemokines such as CXCL9 cytokines (IL-6 and IL-10), and ROS as opposed to mild COVID-19. This evidence concerns the gene CXCL9 and COVID-19.